SIGFOX
Condat, a global specialist in surface chemistry including industrial lubricants, today announced its partnership with Sigfox, the world's leading IoT service provider and initiator of the 0G network. With its long-term partner delaware, an internationally renowned integrator of innovative technology solutions, the two companies have created CondatLink, an IoT solution capable of helping tunnel boring machine operators to better manage their supply and stock of sealant on construction sites.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200701005389/en/
Sealant stock management: a major challenge for tunnel construction
With more than 25 years of experience in the field of tunnels, with more than 4,500 km laid, Condat has unique know-how and an international reputation in its sector. In particular, the company is a leader in the manufacture and supply of tail seal greases, products designed for tunnel construction in wet areas. Tail seal greases are essential for tunnelling especially in the event of water ingress, as job sites risk being delayed and, in the worst case, may even be submerged.
Condat delivers all over the world using 20-ton containers. Until now Condit’s sales teams worked with customers to estimate requirements, without being able to obtain precise information on sealant consumption.
"We needed a solution to prevent our tunnel boring machine customers from running out of sealant on their sites. In the life of a construction site, many parameters can speed up or slow down the consumption of this product. To satisfy our customers, we had to think of a way to find out about it, without having to contact someone on the worksites. We had the feeling that IoT was the right way to go, so we turned to delaware, our technology solutions partner of more than 23 years, to help us," explains Guy Chemisky, Director of Operations at Condat.
CondatLink started as a concept last November at Del20, the delaware working group focused on innovation, where concrete cases and feedback are shared, and in January, the project was launched:
"We started this project together by working on an end-to-end strategy: from the ideas phase to the design of the applications. We then put several people from the IoT ecosystem in touch with each other. Sigfox was chosen to support us during the implementation of this project and the design of the tracking and monitoring equipment," adds Baptiste Duriez, Partner at delaware.
Sigfox was chosen by Condat for its 0G network covering more than 70 countries and regions and its proposal to fully integrate the solution into Condat's SAP environment.
"We were very delighted by the maturity of the thinking. The Condat and delaware teams had carried out an in-depth study of the service experience expected for users and how the solution would fit into production. Even the notion of return on investment with stock management had been analysed. We were therefore able to bring our expertise to the project to introduce a solution very quickly," says Patrick Cason, Managing Director of Sigfox France.
"This project was carried out thanks to a dozen-strong team from Condat, delaware and Sigfox. By combining all these skills, the spirit of innovating together and the desire to co-develop with our suppliers, we managed to finalize this project in a very short timeframe and in the middle of a period of lockdown," adds Guy Chemisky.
The IoT for better consumption monitoring on construction sites
Sigfox's expertise has led to the implementation of the CondatLink solution, which will be available internationally and will enable more precise information about the level of consumption of sealant on building sites, thanks to a connected device that monitors the opening and closing of sealant drums.
The device is attached to the drums as soon as they leave the production plant. It is small (116x45x30mm), light (around 100g) and has, at least, a one-year battery life. As for the software, it uses Sigfox Monarch (international device, frequency management) and Atlas (geolocation) technologies. It will emit a message regularly to signal the location of the drum (asset tracking) while emitting regular messages indicating its change of state when the drum is opened (asset monitoring).
The information obtained by this connected device is sent to Condat and their clients via the Sigfox 0G network and available on a dedicated tracking application. This platform will take the form of a dashboard allowing the customer to track consumption and stock, and Condat to manage its deliveries worldwide.
Aware of environmental issues, Condat has been offering solutions for more than 20 years that are more respectful of individuals and the planet. The development of CondatLink is part of this approach. Thus, with delaware and Sigfox, Condat wanted to pay particular attention to the ecodesign and optimization of the battery. Moreover, the optimisation of transport and the better planning of deliveries, obtained via this solution, enable the company to avoid air transport as much as possible and, therefore, to greatly reduce carbon footprint.
A first use case that aims to deploy tens of thousands of connected objects
A test phase is planned for July with the implementation of this solution over two sites. Initially, the challenge will be the deployment of tens of thousands of objects by next year.
"Tomorrow, we will be able to go further than just monitoring the consumption of sealant on building sites. It will be possible to do this with many other products and for sectors other than tunnel builders. One of our major technological challenges in the coming years will be to make greater use of the data we have been collecting for more than 20 years to build predictive models and serve our customers better ," concludes Guy Chemisky.
About Sigfox
Sigfox is the initiator of the 0G network and the world’s leading IoT (Internet of Things) service provider. Its global network allows billions of devices to connect to the Internet, in a straightforward way, while consuming as little energy as possible. Sigfox’s unique approach to device-to-cloud communications addresses the three greatest barriers to global IoT adoption: cost, energy consumption and global scalability.
Today, the network is available in 70+ countries, with 1 billion people covered. ISO 9001 certified and surrounded by a large ecosystem of partners and IoT key players, Sigfox empowers companies to move their business model towards more digital services, in key areas such as Asset Tracking and Supply Chain. Founded in 2010 by Ludovic Le Moan and Christophe Fourtet, the company is headquartered in France and has offices in Madrid, Munich, Boston, Dallas, San Jose, Dubai, Singapore, Sao Paulo and Tokyo.
About Condat
Condat, an independent international group of French origin, formulates and manufactures a complete range of lubricants and special chemicals for the world of industry.
With proven technical and sales expertise over 160 years, the CONDAT group offers one of the widest ranges on the market, and knows how to satisfy the requirements of many fields of application: wire drawing, tunnel boring, forging, glass, machining, industrial maintenance...
CONDAT recommends to its customers the best lubrication solution from a technical and economical point of view, while taking into account environmental and safety issues.
Leader in tunnelling:
Since 1989, Condat has been developing a complete range of products, lubricants and additives meeting the technical, safety and environmental requirements of underground works such as : tails seal greases, main bearing tail seal greases, hydraulic fluids, foaming agents and polymers, additives for ground treatment... CONDAT, worldwide leader on this application, offers a complete range of biodegradable and fire resistant products dedicated to this market. With the support of a dedicated team of experts and complete services (training, advice...), CONDAT does its utmost to support tunnel specialists whatever the type of tunnel boring machine and the constraints of the construction site.
About delaware
delaware is a global company that delivers advanced ICT solutions and services, recognized on the French market and internationally, delaware helps companies in the daily use of their information system, thanks to its 350 experts based in Lyon, Lille, Nantes, Paris, and Bordeaux. delaware is an internationally renowned company, present in 12 countries with 24 offices.
delaware guides its clients throughout the transformation of their business by relying on its local agencies and deploying the solutions of its main business partners SAP & Microsoft.
Business transformation, next-gen applications, customer connection, data and analysis, applied innovations, information management, maintenance, training: delaware supports its customers in their digital transformation thanks to the most innovative technologies (next-gen erp, artificial intelligence, blockchain, cloud, intelligent applications, IoT, virtual and augmented reality, chatbot, etc.), particularly in the retail, food and beverage, automotive, engineering and professional services industries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005389/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release
Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release
Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
